Schedule 13D ownership disclosure
MBX Biosciences Inc
Security class unavailable · CUSIP: 55287L101
Event date: 2024-09-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.5000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001193125-24-223402
- Form type
- SC 13D
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Sep 23, 2024
- Reporting period
- Sep 16, 2024
- Description
- Schedule 13D beneficial ownership